The mechanism of the adjuvant action of liposomal lipid A is partly due to increased antigen presentation by macrophages and partly due to the recruitment of an increased number of macrophages serving as antigen-presenting cells. Vial with 8.8 mg MPL per ml. VanCott TC, Kaminski R, Lewis M, Mascola J, Wassef N, Alving C, Ulrich T, Richardson C, Lowell G, Burnett P, et al. Mucosal and systemic immune responses to parenteral and intranasal administration of an oligomeric HIV-1 gp160 vaccine. Ann N Y Acad Sci.
Liposome s as carriers for vaccines.
A derivatives as adjuvants for human malaria vaccines. Am J Trop Med Hyg. Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Always watch for outdated information. This article first appeared in 1999.